chr10-99877141-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_015221.4(DNMBP):c.*10G>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00201 in 1,597,454 control chromosomes in the GnomAD database, including 57 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).
Frequency
Genomes: 𝑓 0.010 ( 33 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 24 hom. )
Consequence
DNMBP
NM_015221.4 3_prime_UTR
NM_015221.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.213
Genes affected
DNMBP (HGNC:30373): (dynamin binding protein) This gene encodes a protein belonging to the guanine nucleotide exchange factor family, and which regulates the configuration of cell junctions. It contains multiple binding sites for dynamin and thus links dynamin to actin regulatory proteins. Polymorphisms in this gene have been linked to Alzheimer's disease in some populations, though there are conflicting reports of such linkages in other populations. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 10-99877141-C-G is Benign according to our data. Variant chr10-99877141-C-G is described in ClinVar as [Benign]. Clinvar id is 3038451.Status of the report is no_assertion_criteria_provided, 0 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0102 (1554/152198) while in subpopulation AFR AF= 0.0352 (1460/41510). AF 95% confidence interval is 0.0337. There are 33 homozygotes in gnomad4. There are 741 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 33 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNMBP | NM_015221.4 | c.*10G>C | 3_prime_UTR_variant | 17/17 | ENST00000324109.9 | NP_056036.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNMBP | ENST00000324109.9 | c.*10G>C | 3_prime_UTR_variant | 17/17 | 1 | NM_015221.4 | ENSP00000315659 | P1 | ||
DNMBP | ENST00000543621.6 | c.*10G>C | 3_prime_UTR_variant | 14/14 | 1 | ENSP00000443657 | ||||
DNMBP | ENST00000636706.1 | c.*10G>C | 3_prime_UTR_variant | 14/14 | 2 | ENSP00000489875 |
Frequencies
GnomAD3 genomes AF: 0.0101 AC: 1541AN: 152080Hom.: 31 Cov.: 32
GnomAD3 genomes
AF:
AC:
1541
AN:
152080
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00272 AC: 634AN: 232768Hom.: 10 AF XY: 0.00201 AC XY: 253AN XY: 125856
GnomAD3 exomes
AF:
AC:
634
AN:
232768
Hom.:
AF XY:
AC XY:
253
AN XY:
125856
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00115 AC: 1661AN: 1445256Hom.: 24 Cov.: 31 AF XY: 0.00101 AC XY: 722AN XY: 718064
GnomAD4 exome
AF:
AC:
1661
AN:
1445256
Hom.:
Cov.:
31
AF XY:
AC XY:
722
AN XY:
718064
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0102 AC: 1554AN: 152198Hom.: 33 Cov.: 32 AF XY: 0.00996 AC XY: 741AN XY: 74416
GnomAD4 genome
AF:
AC:
1554
AN:
152198
Hom.:
Cov.:
32
AF XY:
AC XY:
741
AN XY:
74416
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
14
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
DNMBP-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 18, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at